Role of IgA receptors in the pathogenesis of IgA nephropathy

Journal of Nephrology

Volumn 29, Issue 1, 2016, Pages 5-11

  Lechner, Sebastian M ^a,b,c,d   Papista, Christina ^a,b,c,d   Chemouny, Jonathan M ^a,b,c,d   Berthelot, Laureline ^a,b,c,d   Monteiro, Renato C ^a,b,c,d,e  

^a INSERM   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c Inflamex Laboratory of Excellence Site Xavier Bichat   (France)

^d CNRS   (France)

^e BICHAT HOSPITAL   (France)

Author keywords

CD89; Gluten; IgA glycosylation; IgA nephropathy; IgA receptors; Primary glomerulonephritis

Indexed keywords

CD89 RECEPTOR; FC RECEPTOR; GLIADIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN RECEPTOR; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE 2; UNCLASSIFIED DRUG; CD71 ANTIGEN; FC(ALPHA) RECEPTOR; IGA RECEPTOR; LEUKOCYTE ANTIGEN; LIGAND; TRANSFERRIN RECEPTOR;

CELIAC DISEASE; CELL ACTIVATION; GLOMERULONEPHRITIS; HEMATURIA; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; MESANGIUM; MESANGIUM CELL; NONHUMAN; PROTEIN EXPRESSION; REVIEW; ANIMAL; DIET THERAPY; DISEASE MODEL; GLOMERULONEPHRITIS, IGA; GLOMERULUS; GLUTEN FREE DIET; IMMUNOLOGY; METABOLISM; PATHOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; ANTIGENS, CD; CELIAC DISEASE; DIET, GLUTEN-FREE; DISEASE MODELS, ANIMAL; GLIADIN; GLOMERULONEPHRITIS, IGA; HUMANS; IMMUNOGLOBULIN A; KIDNEY GLOMERULUS; LIGANDS; RECEPTORS, FC; RECEPTORS, TRANSFERRIN; SIGNAL TRANSDUCTION;

EID: 84961317428     PISSN: 11218428     EISSN: 17246059     Source Type: Journal    
DOI: 10.1007/s40620-015-0246-5     Document Type: Review

References (64)

1. Kerr MA (1990) The structure and function of human IgA. Biochem J 271:285–296
2. Solomon A (1980) Monoclonal immunoglobulins as biomarkers of cancer. In: Sell S (ed) Cancer markers. Humana Press, New York, pp 57–87
3. Phalipon A, Corthésy B (2003) Novel functions of the polymeric Ig receptor: well beyond transport of immunoglobulins. Trends Immunol 24:55–58
4. Boehm MK, Woof JM, Kerr MA, Perkins SJ (1999) The fab and fc fragments of IgA1 exhibit a different arrangement from that in IgG: a study by X-ray and neutron solution scattering and homology modelling1. J Mol Biol 286:1421–1447. doi:10.1006/jmbi.1998.2556
5. Woof JM, Kerr MA (2006) The function of immunoglobulin A in immunity. J Pathol 208:270–282. doi:10.1002/path.1877
6. Monteiro RC, Van De Winkel JGJ (2003) IgA Fc receptors. Annu Rev Immunol 21:177–204. doi:10.1146/annurev.immunol.21.120601.141011
7. Mestecky J, Tomana M, Moldoveanu Z et al (2008) Role of aberrant glycosylation of IgA1 molecules in the pathogenesis of IgA nephropathy. Kidney Blood Press Res 31:29–37. doi:10.1159/000112922
8. Van Epps DE, Williams RC (1976) Suppression of leukocyte chemotaxis by human IgA myeloma components. J Exp Med 144:1227–1242. doi:10.1084/jem.144.5.1227
9. Van Epps DE, Reed K, Williams RC (1978) Suppression of human PMN bactericidal activity by human IgA paraproteins. Cell Immunol 36:363–376
10. Wilton JMA (1978) Suppression by IgA of IgG-mediated phagocytosis by human polymorphonuclear leucocytes. Clin Exp Immunol 34:423–428
11. Wolf HM, Fischer MB, Puhringer H et al (1994) Human serum IgA downregulates the release of inflammatory cytokines (tumor necrosis factor-alpha, interleukin-6) in human monocytes. Blood 83:1278–1288
12. Nikolova EB, Russell MW (1995) Dual function of human IgA antibodies: inhibition of phagocytosis in circulating neutrophils and enhancement of responses in IL-8-stimulated cells. J Leukoc Biol 57:875–882
13. Wolf HM, Hauber I, Gulle H et al (1996) Anti-inflammatory properties of human serum IgA: induction of IL-1 receptor antagonist and FcαR (CD89)-mediated down-regulation of tumour necrosis factor-alpha (TNF-α) and IL-6 in human monocytes. Clin Exp Immunol 105:537–543. doi:10.1046/j.1365-2249.1996.d01-793.x
14. Olas K, Butterweck H, Teschner W et al (2005) Immunomodulatory properties of human serum immunoglobulin A: anti-inflammatory and pro-inflammatory activities in human monocytes and peripheral blood mononuclear cells. Clin Exp Immunol 140:478–490. doi:10.1111/j.1365-2249.2005.02779.x
15. Jacob CMA, Pastorino AC, Fahl K et al (2008) Autoimmunity in IgA deficiency: revisiting the role of IgA as a silent housekeeper. J Clin Immunol 28(Suppl 1):S56–S61. doi:10.1007/s10875-007-9163-2
16. Ludvigsson JF, Neovius M, Hammarström L (2014) Association between IgA deficiency and other autoimmune conditions: a population-based matched cohort study. J Clin Immunol 34:444–451. doi:10.1007/s10875-014-0009-4
17. Diana J, Moura IC, Vaugier C et al (2013) Secretory IgA induces tolerogenic dendritic cells through SIGNR1 dampening autoimmunity in mice. J Immunol 191:2335–2343. doi:10.4049/jimmunol.1300864
18. Wines BD, Sardjono CT, Trist HM et al (2001) The interaction of FcαRI with IgA and its implications for ligand binding by immunoreceptors of the leukocyte receptor cluster. J Immunol 166:1781–1789. doi:10.4049/jimmunol.166.3.1781
19. Lawrence DA, Weigle WO, Spiegelberg HL (1975) Immunoglobulins cytophilic for human lymphocytes, monocytes, and neutrophils. J Clin Invest 55:368–376
20. Grossetête B, Launay P, Lehuen A et al (1998) Down-regulation of Fc alpha receptors on blood cells of IgA nephropathy patients: evidence for a negative regulatory role of serum IgA. Kidney Int 53:1321–1335. doi:10.1046/j.1523-1755.1998.00885.x
21. Pasquier B, Launay P, Kanamaru Y et al (2005) Identification of FcαRI as an inhibitory receptor that controls inflammation: dual role of FcRγ ITAM. Immunity 22:31–42. doi:10.1016/j.immuni.2004.11.017
22. Rossato E, Ben Mkaddem S, Kanamaru Y et al (2015) Reversal of arthritis by human monomeric IgA through the receptor-mediated SH2 domain-containing phosphatase 1 inhibitory pathway. Arthritis Rheumatol 67:1766–1777. doi:10.1002/art.39142
23. Launay P, Patry C, Lehuen A et al (1999) Alternative endocytic pathway for immunoglobulin A Fc receptors (CD89) depends on the lack of FcRgamma association and protects against degradation of bound ligand. J Biol Chem 274:7216–7225
24. Herr AB, Ballister ER, Bjorkman PJ (2003) Insights into IgA-mediated immune responses from the crystal structures of human FcαRI and its complex with IgA1-Fc. Nature 423:614–620. doi:10.1038/nature01685
25. Davis RS, Dennis G Jr, Odom MR et al (2002) Fc receptor homologs: newest members of a remarkably diverse Fc receptor gene family. Immunol Rev 190:123–136. doi:10.1034/j.1600-065X.2002.19009.x
26. Blank U, Launay P, Benhamou M, Monteiro RC (2009) Inhibitory ITAMs as novel regulators of immunity. Immunol Rev 232:59–71. doi:10.1111/j.1600-065X.2009.00832.x
27. Kanamaru Y, Pfirsch S, Aloulou M et al (2008) Inhibitory ITAM signaling by FcαRI-FcRγ chain controls multiple activating responses and prevents renal inflammation. J Immunol 180:2669–2678. doi:10.4049/jimmunol.180.4.2669
28. Launay P, Lehuen A, Kawakami T et al (1998) IgA Fc receptor (CD89) activation enables coupling to syk and Btk tyrosine kinase pathways: differential signaling after IFN-gamma or phorbol ester stimulation. J Leukoc Biol 63:636–642
29. Kanamaru Y, Arcos-Fajardo M, Moura IC et al (2007) Fcα receptor I activation induces leukocyte recruitment and promotes aggravation of glomerulonephritis through the FcRγ adaptor. Eur J Immunol 37:1116–1128. doi:10.1002/eji.200636826
30. Monteiro RC, Halbwachs-Mecarelli L, Roque-Barreira MC et al (1985) Charge and size of mesangial IgA in IgA nephropathy. Kidney Int 28:666–671
31. Delacroix DL, Elkom KB, Geubel AP et al (1983) Changes in size, subclass, and metabolic properties of serum immunoglobulin A in liver diseases and in other diseases with high serum immunoglobulin A. J Clin Invest 71:358–367
32. Montenegro V, Monteiro RC (1999) Elevation of serum IgA in spondyloarthropathies and IgA nephropathy and its pathogenic role. Curr Opin Rheumatol 11:265–272
33. Almogren A, Kerr MA (2008) Irreversible aggregation of the Fc fragment derived from polymeric but not monomeric serum IgA1—Implications in IgA-mediated disease. Mol Immunol 45:87–94. doi:10.1016/j.molimm.2007.05.002
34. Allen AC, Bailey EM, Brenchley PEC et al (2001) Mesangial IgA1 in IgA nephropathy exhibits aberrant O-glycosylation: observations in three patients. Kidney Int 60:969–973. doi:10.1046/j.1523-1755.2001.060003969.x
35. Novak J, Julian BA, Tomana M, Mestecky J (2008) IgA glycosylation and IgA immune complexes in the pathogenesis of IgA Nephropathy. Semin Nephrol 28:78–87. doi:10.1016/j.semnephrol.2007.10.009
36. Tomana M, Novak J, Julian BA et al (1999) Circulating immune complexes in IgA nephropathy consist of IgA1 with galactose-deficient hinge region and antiglycan antibodies. J Clin Invest 104:73–81
37. Suzuki H, Moldoveanu Z, Hall S et al (2008) IgA1-secreting cell lines from patients with IgA nephropathy produce aberrantly glycosylated IgA1. J Clin Invest 118:629–639. doi:10.1172/JCI33189
38. Berthoux F, Suzuki H, Thibaudin L et al (2012) Autoantibodies targeting galactose-deficient IgA1 associate with progression of IgA nephropathy. J Am Soc Nephrol 23:1579–1587. doi:10.1681/ASN.2012010053
39. Kokubo T, Hiki Y, Iwase H et al (1997) Evidence for involvement of IgA1 hinge glycopeptide in the IgA1-IgA1 interaction in IgA nephropathy. J Am Soc Nephrol 8:915–919
40. Grossetête B, Viard JP, Lehuen A et al (1995) Impaired Fc alpha receptor expression is linked to increased immunoglobulin A levels and disease progression in HIV-1-infected patients. AIDS Lond Engl 9:229–234
41. Silvain C, Patry C, Launay P et al (1995) Altered expression of monocyte IgA Fc receptors is associated with defective endocytosis in patients with alcoholic cirrhosis. Potential role for IFN-gamma. J Immunol 155:1606–1618
42. Montenegro V, Chiamolera M, Launay P et al (2000) Impaired expression of IgA Fc receptors (CD89) by blood phagocytic cells in ankylosing spondylitis. J Rheumatol 27:411–417
43. Launay P, Grossetête B, Arcos-Fajardo M et al (2000) Fcalpha receptor (CD89) mediates the development of immunoglobulin A (IgA) nephropathy (Berger’s disease). Evidence for pathogenic soluble receptor-Iga complexes in patients and CD89 transgenic mice. J Exp Med 191:1999–2009
44. Berthelot L, Robert T, Vuiblet V et al (2015) Recurrent IgA nephropathy is predicted by altered glycosylated IgA, autoantibodies and soluble CD89 complexes. Kidney Int. doi:10.1038/ki.2015.158
45. Monteiro RC, Moura IC, Launay P et al (2002) Pathogenic significance of IgA receptor interactions in IgA nephropathy. Trends Mol Med 8:464–468
46. Berthelot L, Papista C, Maciel TT et al (2012) Transglutaminase is essential for IgA nephropathy development acting through IgA receptors. J Exp Med 209:793–806. doi:10.1084/jem.20112005
47. Leung JCK, Tsang AWL, Chan DTM, Lai KN (2000) Absence of CD89, polymeric immunoglobulin receptor, and asialoglycoprotein receptor on human mesangial cells. J Am Soc Nephrol 11:241–249
48. Moura IC, Centelles MN, Arcos-Fajardo M et al (2001) Identification of the transferrin receptor as a novel immunoglobulin (Ig)a1 receptor and its enhanced expression on mesangial cells in Iga nephropathy. J Exp Med 194:417–426. doi:10.1084/jem.194.4.417
49. Moura IC, Arcos-Fajardo M, Sadaka C et al (2004) Glycosylation and size of IgA1 are essential for interaction with mesangial transferrin receptor in IgA nephropathy. J Am Soc Nephrol JASN 15:622–634
50. Moura IC, Arcos-Fajardo M, Gdoura A et al (2005) Engagement of transferrin receptor by polymeric IgA1: evidence for a positive feedback loop involving increased receptor expression and mesangial cell proliferation in IgA nephropathy. J Am Soc Nephrol JASN 16:2667–2676. doi:10.1681/ASN.2004111006
51. Tamouza H, Chemouny JM, Raskova Kafkova L et al (2012) The IgA1 immune complex-mediated activation of the MAPK/ERK kinase pathway in mesangial cells is associated with glomerular damage in IgA nephropathy. Kidney Int 82:1284–1296. doi:10.1038/ki.2012.192
52. Monteiro RC (2010) Role of IgA and IgA Fc receptors in inflammation. J Clin Immunol 30:1–9. doi:10.1007/s10875-009-9338-0
53. Collin P, Syrjänen J, Partanen J et al (2002) Celiac disease and HLA DQ in patients with IgA nephropathy. Am J Gastroenterol 97:2572–2576. doi:10.1111/j.1572-0241.2002.06025.x
54. Pasternack A, Collin P, Mustonen J et al (1990) Glomerular IgA deposits in patients with celiac disease. Clin Nephrol 34:56–60
55. Coppo R, Amore A, Roccatello D (1992) Dietary antigens and primary immunoglobulin A nephropathy. J Am Soc Nephrol 2:S173
56. Pierucci A, Fofi C, Bartoli B et al (2002) Antiendomysial antibodies in Berger’s disease. Am J Kidney Dis 39:1176–1182. doi:10.1053/ajkd.2002.33387
57. Amore A, Emancipator SN, Roccatello D et al (1994) Functional consequences of the binding of gliadin to cultured rat mesangial cells: bridging immunoglobulin A to cells and modulation of eicosanoid synthesis and altered cytokine production. Am J Kidney Dis Off J Natl Kidney Found 23:290–301
58. Coppo R, Roccatello D, Amore A et al (1990) Effects of a gluten-free diet in primary IgA nephropathy. Clin Nephrol 33:72–86
59. Kovács T, Kun L, Schmelczer M et al (1996) Do intestinal hyperpermeability and the related food antigens play a role in the progression of IgA nephropathy? I. Study of intestinal permeability. Am J Nephrol 16:500–505
60. Smerud HK, Fellström B, Hällgren R et al (2009) Gluten sensitivity in patients with IgA nephropathy. Nephrol Dial Transplant 24:2476–2481. doi:10.1093/ndt/gfp133
61. Papista C, Berthelot L, Monteiro RC (2011) Dysfunctions of the Iga system: a common link between intestinal and renal diseases. Cell Mol Immunol 8:126–134. doi:10.1038/cmi.2010.69
62. Lebreton C, Ménard S, Abed J et al (2012) Interactions among secretory immunoglobulin A, CD71, and transglutaminase-2 affect permeability of intestinal epithelial cells to gliadin peptides. Gastroenterology 143(698–707):e4. doi:10.1053/j.gastro.2012.05.051
63. Papista C, Lechner S, Ben Mkaddem S et al (2015) Gluten exacerbates IgA nephropathy in humanized mice through gliadin–CD89 interaction. Kidney Int. doi:10.1038/ki.2015.94
64. Matysiak-Budnik T, Moura IC, Arcos-Fajardo M et al (2008) Secretory IgA mediates retrotranscytosis of intact gliadin peptides via the transferrin receptor in celiac disease. J Exp Med 205:143–154. doi:10.1084/jem.20071204